Related Experiment Video
Updated: Jun 1, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Colonic and parastomal ulceration related to nicorandil
Christopher J Payne1, Stuart C Whitelaw
1Department of Surgery, Dumfries and Galloway Royal Infirmary, Dumfries, UK. chrispayne@doctors.org.uk
Abstract:
Nicorandil is an antianginal medication increasingly used in the treatment of severe ischemic heart disease. It has been implicated in the pathogenesis of perianal and perioral ulceration. We report 2 patients with atypical gastrointestinal ulceration due to nicorandil.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease II: Ulcerative Colitis
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

